| Year |
Citation |
Score |
| 2023 |
Mulik S, Berber E, Sehrawat S, Rouse BT. Controlling viral inflammatory lesions by rebalancing immune response patterns. Frontiers in Immunology. 14: 1257192. PMID 37671156 DOI: 10.3389/fimmu.2023.1257192 |
0.337 |
|
| 2023 |
Berber E, Rouse BT. Controlling viral inflammatory lesions by inhibiting fatty acid metabolism. Microbes and Infection. 105141. PMID 37085045 DOI: 10.1016/j.micinf.2023.105141 |
0.384 |
|
| 2023 |
Ren J, Antony F, Rouse BT, Suryawanshi A. Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis. Pathogens (Basel, Switzerland). 12. PMID 36986359 DOI: 10.3390/pathogens12030437 |
0.371 |
|
| 2022 |
Berber E, Rouse BT. Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin. Journal of Virology. e0068822. PMID 35862706 DOI: 10.1128/jvi.00688-22 |
0.315 |
|
| 2021 |
Sumbria D, Berber E, Miller L, Rouse BT. Modulating glutamine metabolism to control viral immuno-inflammatory lesions. Cellular Immunology. 370: 104450. PMID 34678554 DOI: 10.1016/j.cellimm.2021.104450 |
0.414 |
|
| 2021 |
Berber E, Sumbria D, Newkirk KM, Rouse BT. Inhibiting Glucose Metabolism Results in Herpes Simplex Encephalitis. Journal of Immunology (Baltimore, Md. : 1950). 207: 1824-1835. PMID 34470854 DOI: 10.4049/jimmunol.2100453 |
0.402 |
|
| 2020 |
Sumbria D, Berber E, Rouse BT. Supplementing the diet with sodium propionate suppresses the severity of viral immuno-inflammatory lesions. Journal of Virology. PMID 33208449 DOI: 10.1128/JVI.02056-20 |
0.391 |
|
| 2020 |
Sehrawat S, Rouse BT. Opinion: Does the hygiene hypothesis apply to COVID-19 susceptibility? Microbes and Infection. PMID 32653475 DOI: 10.1016/J.Micinf.2020.07.002 |
0.375 |
|
| 2020 |
Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Host-Directed Antiviral Therapy. Clinical Microbiology Reviews. 33. PMID 32404434 DOI: 10.1128/Cmr.00168-19 |
0.351 |
|
| 2019 |
Sumbria D, Berber E, Rouse BT. Factors Affecting the Tissue Damaging Consequences of Viral Infections. Frontiers in Microbiology. 10: 2314. PMID 31636623 DOI: 10.3389/Fmicb.2019.02314 |
0.405 |
|
| 2019 |
Rajasagi NK, Rouse BT. The Role of T Cells in Herpes Stromal Keratitis. Frontiers in Immunology. 10: 512. PMID 30941142 DOI: 10.3389/Fimmu.2019.00512 |
0.506 |
|
| 2019 |
Machala EA, McSharry BP, Rouse BT, Abendroth A, Slobedman B. Gal power: the diverse roles of galectins in regulating viral infections. The Journal of General Virology. PMID 30648945 DOI: 10.1099/Jgv.0.001208 |
0.462 |
|
| 2018 |
Varanasi SK, Rajasagi NK, Jaggi U, Rouse BT. Role of IL-18 induced Amphiregulin expression on virus induced ocular lesions. Mucosal Immunology. PMID 30087443 DOI: 10.1038/S41385-018-0058-8 |
0.408 |
|
| 2018 |
Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and Immunological Outcomes of Coinfections. Clinical Microbiology Reviews. 31. PMID 29976554 DOI: 10.1128/Cmr.00111-17 |
0.457 |
|
| 2018 |
Sehrawat S, Kumar D, Rouse BT. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases? Frontiers in Cellular and Infection Microbiology. 8: 177. PMID 29888215 DOI: 10.3389/Fcimb.2018.00177 |
0.386 |
|
| 2018 |
Jaggi U, Varanasi SK, Bhela S, Rouse BT. On the Role of Retinoic Acid in virus induced Inflammatory Response in Cornea. Microbes and Infection. PMID 29842984 DOI: 10.1016/J.Micinf.2018.04.007 |
0.435 |
|
| 2018 |
Varanasi SK, Jaggi U, Hay N, Rouse BT. Hexokinase II may be dispensable for CD4 T cell responses against a virus infection. Plos One. 13: e0191533. PMID 29352298 DOI: 10.1371/Journal.Pone.0191533 |
0.518 |
|
| 2018 |
Rajasagi NK, Rouse BT. Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy. Microbes and Infection. PMID 29329934 DOI: 10.1016/J.Micinf.2017.12.014 |
0.367 |
|
| 2017 |
Bhela S, Rouse BT. Are miRNAs critical determinants in Herpes Simplex Virus pathogenesis? Microbes and Infection. PMID 29287990 DOI: 10.1016/J.Micinf.2017.12.007 |
0.318 |
|
| 2017 |
Varanasi SK, Rouse BT. How host metabolism impacts on virus pathogenesis. Current Opinion in Virology. 28: 37-42. PMID 29156318 DOI: 10.1016/J.Coviro.2017.11.003 |
0.387 |
|
| 2017 |
Bhela S, Rouse BT. miR-31: a key player in CD8 T-cell exhaustion. Cellular & Molecular Immunology. PMID 28890544 DOI: 10.1038/Cmi.2017.89 |
0.331 |
|
| 2017 |
Varanasi SK, Donohoe D, Jaggi U, Rouse BT. Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects. Journal of Immunology (Baltimore, Md. : 1950). PMID 28768727 DOI: 10.4049/Jimmunol.1700472 |
0.456 |
|
| 2017 |
Bhela S, Varanasi SK, Jaggi U, Sloan SS, Rajasagi NK, Rouse BT. The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions. Journal of Immunology (Baltimore, Md. : 1950). PMID 28710254 DOI: 10.4049/Jimmunol.1700520 |
0.502 |
|
| 2017 |
Rajasagi NK, Bhela S, Varanasi SK, Rouse BT. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. Journal of Leukocyte Biology. PMID 28584076 DOI: 10.1189/Jlb.3Hi1216-511Rr |
0.507 |
|
| 2017 |
Sehrawat S, Rouse BT. Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals. Frontiers in Immunology. 8: 341. PMID 28421070 DOI: 10.3389/Fimmu.2017.00341 |
0.493 |
|
| 2017 |
Varanasi SK, Reddy PB, Bhela S, Jaggi U, Gimenez F, Rouse BT. Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. Journal of Virology. PMID 28100624 DOI: 10.1128/Jvi.02367-16 |
0.547 |
|
| 2016 |
Rajasagi NK, Rouse BT. IL-2 complex treatment amplifies CD8(+) T cell mediated immunity following herpes simplex virus-1 infection. Microbes and Infection. PMID 27866863 DOI: 10.1016/J.Micinf.2016.10.010 |
0.525 |
|
| 2016 |
Rouse BT, Mueller SN. Some vexations that challenge viral immunology. F1000research. 5. PMID 27303640 DOI: 10.12688/F1000Research.8391.1 |
0.402 |
|
| 2015 |
Gimenez F, Mulik S, Veiga-Parga T, Bhela S, Rouse BT. Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis. Plos One. 10: e0141925. PMID 26720197 DOI: 10.1371/Journal.Pone.0141925 |
0.41 |
|
| 2015 |
Gimenez F, Bhela S, Dogra P, Harvey L, Varanasi SK, Jaggi U, Rouse BT. The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion. Journal of Leukocyte Biology. PMID 26516184 DOI: 10.1189/Jlb.3Hi0715-321R |
0.515 |
|
| 2015 |
Bhela S, Mulik S, Gimenez F, Reddy PB, Richardson RL, Varanasi SK, Jaggi U, Xu J, Lu PY, Rouse BT. Role of miR-155 in the pathogenesis of herpetic stromal keratitis. The American Journal of Pathology. 185: 1073-84. PMID 25700796 DOI: 10.1016/J.Ajpath.2014.12.021 |
0.437 |
|
| 2014 |
Mayer CT, Lahl K, Milanez-Almeida P, Watts D, Dittmer U, Fyhrquist N, Huehn J, Kopf M, Kretschmer K, Rouse B, Sparwasser T. Advantages of Foxp3(+) regulatory T cell depletion using DEREG mice. Immunity, Inflammation and Disease. 2: 162-5. PMID 25505550 DOI: 10.1002/Iid3.33 |
0.453 |
|
| 2014 |
Sharma S, Rajasagi NK, Veiga-Parga T, Rouse BT. Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. Microbes and Infection / Institut Pasteur. 16: 648-60. PMID 24956596 DOI: 10.1016/J.Micinf.2014.06.005 |
0.552 |
|
| 2014 |
Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Khatri M, Rouse BT. An approach to control relapse of inflammatory lesions after discontinuation of primary therapy. Plos One. 9: e98051. PMID 24846129 DOI: 10.1371/Journal.Pone.0098051 |
0.444 |
|
| 2014 |
Bhela S, Mulik S, Reddy PB, Richardson RL, Gimenez F, Rajasagi NK, Veiga-Parga T, Osmand AP, Rouse BT. Critical role of microRNA-155 in herpes simplex encephalitis. Journal of Immunology (Baltimore, Md. : 1950). 192: 2734-43. PMID 24516198 DOI: 10.4049/Jimmunol.1302326 |
0.439 |
|
| 2013 |
Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunological Reviews. 255: 182-96. PMID 23947355 DOI: 10.1111/Imr.12085 |
0.537 |
|
| 2013 |
Rajasagi NK, Reddy PB, Mulik S, Gjorstrup P, Rouse BT. Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Investigative Ophthalmology & Visual Science. 54: 6269-79. PMID 23942967 DOI: 10.1167/Iovs.13-12152 |
0.483 |
|
| 2013 |
Veiga-Parga T, Giménez F, Mulik S, Chiang EY, Grogan JL, Rouse BT. Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes and Infection / Institut Pasteur. 15: 677-87. PMID 23850656 DOI: 10.1016/J.Micinf.2013.07.001 |
0.431 |
|
| 2013 |
Giménez F, Suryawanshi A, Rouse BT. Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Progress in Retinal and Eye Research. 33: 1-9. PMID 22892644 DOI: 10.1016/J.Preteyeres.2012.07.002 |
0.422 |
|
| 2012 |
Veiga-Parga T, Suryawanshi A, Mulik S, Giménez F, Sharma S, Sparwasser T, Rouse BT. On the role of regulatory T cells during viral-induced inflammatory lesions. Journal of Immunology (Baltimore, Md. : 1950). 189: 5924-33. PMID 23129753 DOI: 10.4049/Jimmunol.1202322 |
0.517 |
|
| 2012 |
J Reddy PB, Schreiber TH, Rajasagi NK, Suryawanshi A, Mulik S, Veiga-Parga T, Niki T, Hirashima M, Podack ER, Rouse BT. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. Journal of Virology. 86: 10606-20. PMID 22811539 DOI: 10.1128/Jvi.01391-12 |
0.524 |
|
| 2012 |
Mulik S, Xu J, Reddy PB, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. The American Journal of Pathology. 181: 525-34. PMID 22659469 DOI: 10.1016/J.Ajpath.2012.04.014 |
0.383 |
|
| 2012 |
Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, Hirashima M, Rouse BT. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. Journal of Immunology (Baltimore, Md. : 1950). 188: 4631-43. PMID 22467659 DOI: 10.4049/Jimmunol.1103063 |
0.511 |
|
| 2012 |
Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 3434-46. PMID 22379030 DOI: 10.4049/Jimmunol.1102602 |
0.346 |
|
| 2011 |
Veiga-Parga T, Suryawanshi A, Rouse BT. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. Plos Pathogens. 7: e1002427. PMID 22174686 DOI: 10.1371/Journal.Ppat.1002427 |
0.501 |
|
| 2011 |
Sharma S, Sundararajan A, Suryawanshi A, Kumar N, Veiga-Parga T, Kuchroo VK, Thomas PG, Sangster MY, Rouse BT. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proceedings of the National Academy of Sciences of the United States of America. 108: 19001-6. PMID 22052881 DOI: 10.1073/Pnas.1107087108 |
0.54 |
|
| 2011 |
Reddy PB, Sehrawat S, Suryawanshi A, Rajasagi NK, Mulik S, Hirashima M, Rouse BT. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. Journal of Immunology (Baltimore, Md. : 1950). 187: 5745-55. PMID 22021615 DOI: 10.4049/Jimmunol.1102105 |
0.51 |
|
| 2011 |
Sehrawat S, Rouse BT. Tregs and infections: on the potential value of modifying their function. Journal of Leukocyte Biology. 90: 1079-87. PMID 21914856 DOI: 10.1189/Jlb.0611271 |
0.495 |
|
| 2011 |
Suryawanshi A, Veiga-Parga T, Rajasagi NK, Reddy PB, Sehrawat S, Sharma S, Rouse BT. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. Journal of Immunology (Baltimore, Md. : 1950). 187: 1919-30. PMID 21765013 DOI: 10.4049/Jimmunol.1100736 |
0.481 |
|
| 2011 |
Mulik S, Sharma S, Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT. Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. Journal of Immunology (Baltimore, Md. : 1950). 186: 7195-204. PMID 21572022 DOI: 10.4049/Jimmunol.1100014 |
0.342 |
|
| 2011 |
Sharma S, Mulik S, Kumar N, Suryawanshi A, Rouse BT. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. Journal of Virology. 85: 5995-6007. PMID 21471229 DOI: 10.1128/Jvi.00034-11 |
0.44 |
|
| 2011 |
Suryawanshi A, Mulik S, Sharma S, Reddy PB, Sehrawat S, Rouse BT. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. Journal of Immunology (Baltimore, Md. : 1950). 186: 3653-65. PMID 21325621 DOI: 10.4049/Jimmunol.1003239 |
0.369 |
|
| 2011 |
Mott KR, Gate D, Zandian M, Allen SJ, Rajasagi NK, van Rooijen N, Chen S, Arditi M, Rouse BT, Flavell RA, Town T, Ghiasi H. Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Investigative Ophthalmology & Visual Science. 52: 2321-33. PMID 21220560 DOI: 10.1167/Iovs.10-6536 |
0.501 |
|
| 2011 |
Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. Journal of Immunology (Baltimore, Md. : 1950). 186: 1735-46. PMID 21187448 DOI: 10.4049/Jimmunol.1003456 |
0.518 |
|
| 2010 |
Rouse BT, Lukacher AE. Some unmet challenges in the immunology of viral infections. Discovery Medicine. 10: 363-70. PMID 21034678 |
0.322 |
|
| 2010 |
Araki K, Gangappa S, Dillehay DL, Rouse BT, Larsen CP, Ahmed R. Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. The Journal of Experimental Medicine. 207: 2355-67. PMID 20921283 DOI: 10.1084/Jem.20100124 |
0.517 |
|
| 2010 |
Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nature Reviews. Immunology. 10: 514-26. PMID 20577268 DOI: 10.1038/Nri2802 |
0.426 |
|
| 2010 |
Sehrawat S, Reddy PB, Rajasagi N, Suryawanshi A, Hirashima M, Rouse BT. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. Plos Pathogens. 6: e1000882. PMID 20463811 DOI: 10.1371/Journal.Ppat.1000882 |
0.532 |
|
| 2010 |
Campbell IL, Manders P, Lim S, Terry RL, Getts MT, Getts DR, King NJC, Hofer MJ, Araki K, Gangappa S, Rouse BT, Larsen CP, Ahmed R, Shimizu VS, Diego RPd, et al. Immunity to virus infection (excluding retroviruses) 1 (WS-025a) Chairpersons: Yusuke Yanagi, Nicholas King International Immunology. 22. DOI: 10.1093/Intimm/Dxq181 |
0.403 |
|
| 2009 |
Sehrawat S, Suryawanshi A, Hirashima M, Rouse BT. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. Journal of Immunology (Baltimore, Md. : 1950). 182: 3191-201. PMID 19234217 DOI: 10.4049/Jimmunol.0803673 |
0.491 |
|
| 2009 |
Rodrigues L, Nandakumar S, Bonorino C, Rouse BT, Kumaraguru U. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Molecular Immunology. 46: 1494-504. PMID 19233474 DOI: 10.1016/J.Molimm.2008.12.033 |
0.475 |
|
| 2009 |
Sarangi PP, Woo SR, Rouse BT. Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction. Clinical Immunology (Orlando, Fla.). 131: 31-40. PMID 19070547 DOI: 10.1016/J.Clim.2008.10.008 |
0.498 |
|
| 2008 |
Nandakumar S, Woolard SN, Yuan D, Rouse BT, Kumaraguru U. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. Journal of Virology. 82: 10820-31. PMID 18715907 DOI: 10.1128/Jvi.00365-08 |
0.521 |
|
| 2008 |
Sarangi PP, Kim B, Rouse BT. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis. Investigative Ophthalmology & Visual Science. 49: 5425-33. PMID 18689698 DOI: 10.1167/Iovs.07-1638 |
0.337 |
|
| 2008 |
Suvas S, Kim B, Rouse BT. Homeostatic expansion of CD4(+) T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes and Infection / Institut Pasteur. 10: 1192-200. PMID 18657630 DOI: 10.1016/J.Micinf.2008.06.012 |
0.517 |
|
| 2008 |
Sehrawat S, Rouse BT. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. Journal of Immunology (Baltimore, Md. : 1950). 180: 7636-47. PMID 18490766 DOI: 10.4049/Jimmunol.180.11.7636 |
0.494 |
|
| 2008 |
Sehrawat S, Suvas S, Sarangi PP, Suryawanshi A, Rouse BT. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. Journal of Virology. 82: 6838-51. PMID 18480441 DOI: 10.1128/Jvi.00697-08 |
0.511 |
|
| 2008 |
Sarangi PP, Sehrawat S, Suvas S, Rouse BT. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. Journal of Immunology (Baltimore, Md. : 1950). 180: 6297-306. PMID 18424753 DOI: 10.4049/Jimmunol.180.9.6297 |
0.465 |
|
| 2008 |
Pack CD, Gierynska M, Rouse BT. An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus. Human Vaccines. 4: 360-4. PMID 18382144 DOI: 10.4161/Hv.4.5.5978 |
0.468 |
|
| 2008 |
Kim B, Sarangi PP, Azkur AK, Kaistha SD, Rouse BT. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes and Infection / Institut Pasteur. 10: 302-12. PMID 18325811 DOI: 10.1016/J.Micinf.2007.12.007 |
0.486 |
|
| 2007 |
Rouse BT, Suvas S. Regulatory T cells and immunity to pathogens. Expert Opinion On Biological Therapy. 7: 1301-9. PMID 17727321 DOI: 10.1517/14712598.7.9.1301 |
0.464 |
|
| 2007 |
Sarangi PP, Kim B, Kurt-Jones E, Rouse BT. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. Journal of Virology. 81: 11128-38. PMID 17686871 DOI: 10.1128/Jvi.01008-07 |
0.484 |
|
| 2007 |
Rouse BT. Regulatory T cells in health and disease Journal of Internal Medicine. 262: 78-95. PMID 17598816 DOI: 10.1111/j.1365-2796.2007.01836.x |
0.301 |
|
| 2007 |
Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 65-75. PMID 17266445 DOI: 10.1089/Jir.2007.0077 |
0.796 |
|
| 2007 |
Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, Hanson HL, Steinberg JP, Masopust D, Wherry EJ, Altman JD, Rouse BT, Freeman GJ, Ahmed R, Grakoui A. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. Journal of Virology. 81: 2545-53. PMID 17182670 DOI: 10.1128/Jvi.02021-06 |
0.388 |
|
| 2007 |
Vanitha DJ, Joo HM, Rouse BT, Sangster MY. Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection. Virology. 360: 136-42. PMID 17113122 DOI: 10.1016/J.Virol.2006.10.006 |
0.426 |
|
| 2007 |
Rouse BT, Sehrawat S. Regulatory T Cells and Infectious Disease Immune Network. 7: 167. DOI: 10.4110/In.2007.7.4.167 |
0.473 |
|
| 2006 |
Kim B, Lee S, Kaistha SD, Rouse BT. Application of FGF-2 to modulate herpetic stromal keratitis. Current Eye Research. 31: 1021-8. PMID 17169840 DOI: 10.1080/02713680601038824 |
0.414 |
|
| 2006 |
Kim B, Sarangi PP, Lee Y, Deshpande Kaistha S, Lee S, Rouse BT. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. Journal of Leukocyte Biology. 80: 1405-15. PMID 16997857 DOI: 10.1189/Jlb.0406295 |
0.636 |
|
| 2006 |
Kim B, Suvas S, Sarangi PP, Lee S, Reisfeld RA, Rouse BT. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. Journal of Immunology (Baltimore, Md. : 1950). 177: 4122-31. PMID 16951377 DOI: 10.4049/Jimmunol.177.6.4122 |
0.457 |
|
| 2006 |
Rouse BT, Sarangi PP, Suvas S. Regulatory T cells in virus infections. Immunological Reviews. 212: 272-86. PMID 16903920 DOI: 10.1111/J.0105-2896.2006.00412.X |
0.531 |
|
| 2006 |
Li X, Vanitha DJ, Joo HM, He Y, Rouse BT, Sangster MY. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis. Journal of Immunological Methods. 313: 110-8. PMID 16730022 DOI: 10.1016/J.Jim.2006.03.016 |
0.448 |
|
| 2006 |
Kalia V, Sarkar S, Gourley TS, Rouse BT, Ahmed R. Differentiation of memory B and T cells. Current Opinion in Immunology. 18: 255-64. PMID 16632337 DOI: 10.1016/J.Coi.2006.03.020 |
0.322 |
|
| 2006 |
Suvas S, Rouse BT. Treg control of antimicrobial T cell responses. Current Opinion in Immunology. 18: 344-8. PMID 16616481 DOI: 10.1016/J.Coi.2006.03.005 |
0.458 |
|
| 2006 |
Rouse BT, Masopust D. Waking up T cells to counteract chronic infections. Trends in Immunology. 27: 205-7. PMID 16584922 DOI: 10.1016/J.It.2006.03.008 |
0.459 |
|
| 2006 |
Rouse BT, Kaistha SD. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 810-7. PMID 16477558 DOI: 10.1086/500141 |
0.336 |
|
| 2006 |
Suvas S, Azkur AK, Rouse BT. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. Journal of Immunology (Baltimore, Md. : 1950). 176: 1703-11. PMID 16424200 DOI: 10.4049/Jimmunol.176.3.1703 |
0.471 |
|
| 2006 |
Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 82: 46-54. PMID 16009363 DOI: 10.1016/J.Exer.2005.05.001 |
0.773 |
|
| 2005 |
Kim B, Deshpande Kaistha S, Rouse BT. Viruses and autoimmunity. Autoimmunity. 38: 559-65. PMID 16390809 DOI: 10.1080/08916930500356583 |
0.392 |
|
| 2005 |
Suvas S, Rouse BT. Regulation of microbial immunity: the suppressor cell renaissance. Viral Immunology. 18: 411-8. PMID 16212520 DOI: 10.1089/Vim.2005.18.411 |
0.447 |
|
| 2005 |
Suvas S, Kim B, Sarangi PP, Tone M, Waldmann H, Rouse BT. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. Journal of Virology. 79: 11935-42. PMID 16140769 DOI: 10.1128/Jvi.79.18.11935-11942.2005 |
0.506 |
|
| 2005 |
Kumaraguru U, Banerjee K, Rouse BT. In vivo rescue of defective memory CD8+ T cells by cognate helper T cells. Journal of Leukocyte Biology. 78: 879-87. PMID 16081600 DOI: 10.1189/Jlb.0105007 |
0.705 |
|
| 2005 |
Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, Johnson DC. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proceedings of the National Academy of Sciences of the United States of America. 102: 11462-7. PMID 16055558 DOI: 10.1073/pnas.0503230102 |
0.743 |
|
| 2005 |
Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. Journal of Virology. 79: 10589-600. PMID 16051851 DOI: 10.1128/Jvi.79.16.10589-10600.2005 |
0.761 |
|
| 2005 |
Azkur AK, Kim B, Suvas S, Lee Y, Kumaraguru U, Rouse BT. Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides. 15: 72-84. PMID 15989422 DOI: 10.1089/Oli.2005.15.72 |
0.508 |
|
| 2005 |
Kim B, Lee S, Suvas S, Rouse BT. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. Journal of Immunology (Baltimore, Md. : 1950). 175: 509-16. PMID 15972686 DOI: 10.4049/Jimmunol.175.1.509 |
0.383 |
|
| 2005 |
Biswas PS, Rouse BT. Early events in HSV keratitis--setting the stage for a blinding disease. Microbes and Infection / Institut Pasteur. 7: 799-810. PMID 15857807 DOI: 10.1016/J.Micinf.2005.03.003 |
0.651 |
|
| 2005 |
Pack CD, Kumaraguru U, Suvas S, Rouse BT. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine. 23: 3526-34. PMID 15855011 DOI: 10.1016/J.Vaccine.2005.01.152 |
0.466 |
|
| 2005 |
Toka FN, Rouse BT. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. Journal of Leukocyte Biology. 78: 178-86. PMID 15817700 DOI: 10.1189/Jlb.1004621 |
0.489 |
|
| 2005 |
Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nature Immunology. 6: 353-60. PMID 15785761 DOI: 10.1038/Ni1181 |
0.481 |
|
| 2005 |
Biswas PS, Banerjee K, Kim B, Smith J, Rouse BT. A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Experimental Eye Research. 80: 73-81. PMID 15652528 DOI: 10.1016/J.Exer.2004.08.014 |
0.768 |
|
| 2005 |
Toka FN, Gieryńska M, Suvas S, Schoenberger SP, Rouse BT. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology. 331: 151-8. PMID 15582662 DOI: 10.1016/J.Virol.2004.10.022 |
0.46 |
|
| 2005 |
Banerjee K, Biswas PS, Rouse BT. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. Journal of Leukocyte Biology. 77: 24-32. PMID 15496448 DOI: 10.1189/Jlb.0904486 |
0.8 |
|
| 2005 |
Schmid DS, Rouse BT. Respiratory viral vaccines Mucosal Immunology, Two-Volume Set. 923-936. DOI: 10.1016/B978-012491543-5/50055-3 |
0.382 |
|
| 2004 |
Banerjee K, Biswas PS, Kumaraguru U, Schoenberger SP, Rouse BT. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 7575-83. PMID 15585885 DOI: 10.4049/Jimmunol.173.12.7575 |
0.806 |
|
| 2004 |
Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY, Ansari AM, Scaria PV, Woodle MC, Lu P, Rouse BT. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. The American Journal of Pathology. 165: 2177-85. PMID 15579459 DOI: 10.1016/S0002-9440(10)63267-1 |
0.607 |
|
| 2004 |
Toka FN, Suvas S, Rouse BT. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. Journal of Virology. 78: 13082-9. PMID 15542660 DOI: 10.1128/Jvi.78.23.13082-13089.2004 |
0.468 |
|
| 2004 |
Rouse BT, Suvas S. Regulatory cells and infectious agents: detentes cordiale and contraire. Journal of Immunology (Baltimore, Md. : 1950). 173: 2211-5. PMID 15294929 DOI: 10.4049/Jimmunol.173.4.2211 |
0.485 |
|
| 2004 |
Biswas PS, Banerjee K, Zheng M, Rouse BT. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. Journal of Leukocyte Biology. 76: 868-75. PMID 15258192 DOI: 10.1189/Jlb.0504280 |
0.746 |
|
| 2004 |
Toka FN, Pack CD, Rouse BT. Molecular adjuvants for mucosal immunity. Immunological Reviews. 199: 100-12. PMID 15233729 DOI: 10.1111/J.0105-2896.2004.0147.X |
0.398 |
|
| 2004 |
Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Reviews in Molecular Medicine. 6: 1-14. PMID 15061872 DOI: 10.1017/S1462399404007604 |
0.781 |
|
| 2004 |
Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. Journal of Immunology (Baltimore, Md. : 1950). 172: 4123-32. PMID 15034024 DOI: 10.4049/Jimmunol.172.7.4123 |
0.528 |
|
| 2004 |
Biswas PS, Banerjee K, Kim B, Rouse BT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 172: 3736-44. PMID 15004178 DOI: 10.4049/Jimmunol.172.6.3736 |
0.742 |
|
| 2004 |
Kumaraguru U, Suvas S, Biswas PS, Azkur AK, Rouse BT. Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 3719-24. PMID 15004176 DOI: 10.4049/Jimmunol.172.6.3719 |
0.625 |
|
| 2004 |
Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. Journal of Immunology (Baltimore, Md. : 1950). 172: 1237-45. PMID 14707102 DOI: 10.4049/Jimmunol.172.2.1237 |
0.778 |
|
| 2003 |
Kumaraguru U, Gouffon CA, Ivey RA, Rouse BT, Bruce BD. Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses. Cell Stress & Chaperones. 8: 134-43. PMID 14627199 DOI: 10.1379/1466-1268(2003)008<0134:Apctpd>2.0.Co;2 |
0.381 |
|
| 2003 |
Toka FN, Gierynska M, Rouse BT. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. Journal of Virology. 77: 12742-52. PMID 14610196 DOI: 10.1128/Jvi.77.23.12742-12752.2003 |
0.416 |
|
| 2003 |
Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. The Journal of Experimental Medicine. 198: 889-901. PMID 12975455 DOI: 10.1084/Jem.20030171 |
0.485 |
|
| 2003 |
Lee Y, Eo SK, Rouse RJ, Rouse BT. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. Virology. 312: 169-80. PMID 12890630 DOI: 10.1016/S0042-6822(03)00199-5 |
0.649 |
|
| 2003 |
Lee S, Gierynska M, Eo SK, Kuklin N, Rouse BT. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes and Infection / Institut Pasteur. 5: 571-8. PMID 12787733 DOI: 10.1016/S1286-4579(03)00108-4 |
0.418 |
|
| 2003 |
Kumaraguru U, Pack CD, Rouse BT. Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins. Journal of Leukocyte Biology. 73: 574-83. PMID 12714571 DOI: 10.1189/Jlb.0902470 |
0.402 |
|
| 2002 |
Klinman DM, Zheng M, Gierynska M, Rouse BT. DNA Containing Bioactive CpG Motifs Promote Angiogenesis. Drug News & Perspectives. 15: 358-363. PMID 12677232 DOI: 10.1358/Dnp.2002.15.6.840034 |
0.333 |
|
| 2002 |
Banerjee K, Deshpande S, Zheng M, Kumaraguru U, Schoenberger SP, Rouse BT. Herpetic stromal keratitis in the absence of viral antigen recognition. Cellular Immunology. 219: 108-18. PMID 12576029 DOI: 10.1016/S0008-8749(02)00601-9 |
0.804 |
|
| 2002 |
Blackman MA, Rouse BT, Chisari FV, Woodland DL. Viral immunology: challenges associated with the progression from bench to clinic. Trends in Immunology. 23: 565-7. PMID 12464561 DOI: 10.1016/S1471-4906(02)02343-8 |
0.422 |
|
| 2002 |
Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. The Journal of Clinical Investigation. 110: 1105-11. PMID 12393846 DOI: 10.1172/Jci15755 |
0.351 |
|
| 2002 |
Kumaraguru U, Rouse BT. The IL-12 response to herpes simplex virus is mainly a paracrine response of reactive inflammatory cells. Journal of Leukocyte Biology. 72: 564-70. PMID 12223525 DOI: 10.1189/Jlb.72.3.564 |
0.471 |
|
| 2002 |
Zheng M, Klinman DM, Gierynska M, Rouse BT. DNA containing CpG motifs induces angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 99: 8944-9. PMID 12060721 DOI: 10.1073/Pnas.132605599 |
0.354 |
|
| 2002 |
Gierynska M, Kumaraguru U, Eo SK, Lee S, Krieg A, Rouse BT. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. Journal of Virology. 76: 6568-76. PMID 12050369 DOI: 10.1128/Jvi.76.13.6568-6576.2002 |
0.483 |
|
| 2002 |
Rouse BT, Deshpande S. Viruses and autoimmunity: an affair but not a marriage contract. Reviews in Medical Virology. 12: 107-13. PMID 11921306 DOI: 10.1002/Rmv.347 |
0.652 |
|
| 2002 |
Deshpande SP, Zheng M, Lee S, Rouse BT. Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Veterinary Microbiology. 86: 17-26. PMID 11888686 DOI: 10.1016/S0378-1135(01)00487-4 |
0.653 |
|
| 2002 |
Lee S, Zheng M, Deshpande S, Eo SK, Hamilton TA, Rouse BT. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. Journal of Leukocyte Biology. 71: 469-76. PMID 11867684 DOI: 10.1189/Jlb.71.3.469 |
0.664 |
|
| 2002 |
Kumaraguru U, Gierynska M, Norman S, Bruce BD, Rouse BT. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. Journal of Virology. 76: 136-41. PMID 11739679 DOI: 10.1128/Jvi.76.1.136-141.2002 |
0.493 |
|
| 2002 |
Eo SK, Lee S, Kumaraguru U, Rouse BT. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands. Vaccine. 19: 4685-93. PMID 11535317 DOI: 10.1016/S0264-410X(01)00241-9 |
0.462 |
|
| 2001 |
Rouse BT, Gierynska M. Immunity to herpes simplex virus: A hypothesis Herpes. 8. PMID 11867027 |
0.356 |
|
| 2001 |
Eo SK, Pack C, Kumaraguru U, Rouse BT. Optimisation of DNA vaccines for thé prophylaxis and modulation of herpes simplex virus infections Expert Opinion On Biological Therapy. 1: 213-225. PMID 11727531 DOI: 10.1517/14712598.1.2.213 |
0.358 |
|
| 2001 |
Seong Kug Eo, Kumaraguru U, Rouse BT. Plasmid DNA encoding CCR7 ligands compensate for dysfunctional CD8+ T cell responses by effects on dendritic cells Journal of Immunology. 167: 3592-3599. PMID 11564771 DOI: 10.4049/Jimmunol.167.7.3592 |
0.493 |
|
| 2001 |
Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. Journal of Virology. 75: 9828-35. PMID 11559816 DOI: 10.1128/Jvi.75.20.9828-9835.2001 |
0.646 |
|
| 2001 |
Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT. Control of stromal keratitis by inhibition of neovascularization. The American Journal of Pathology. 159: 1021-9. PMID 11549594 DOI: 10.1016/S0002-9440(10)61777-4 |
0.411 |
|
| 2001 |
Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT. Bystander activation involving T lymphocytes in herpetic stromal keratitis. Journal of Immunology (Baltimore, Md. : 1950). 167: 2902-10. PMID 11509638 DOI: 10.4049/Jimmunol.167.5.2902 |
0.798 |
|
| 2001 |
Eo SK, Gierynska M, Kamar AA, Rouse BT. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. Journal of Immunology (Baltimore, Md. : 1950). 166: 5473-9. PMID 11313385 DOI: 10.4049/Jimmunol.166.9.5473 |
0.367 |
|
| 2001 |
Deshpande SP, Lee S, Zheng M, Song B, Knipe D, Kapp JA, Rouse BT. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. Journal of Virology. 75: 3077-88. PMID 11238834 DOI: 10.1128/Jvi.75.7.3077-3088.2001 |
0.7 |
|
| 2001 |
Mistry SK, Zheng M, Rouse BT, Morris SM. Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Research. 73: 177-82. PMID 11172921 DOI: 10.1016/S0168-1702(00)00243-4 |
0.413 |
|
| 2001 |
Kumaraguru U, Davis IA, Deshpande S, Tevethia SS, Rouse BT. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. Journal of Immunology (Baltimore, Md. : 1950). 166: 1066-74. PMID 11145686 DOI: 10.4049/Jimmunol.166.2.1066 |
0.696 |
|
| 2001 |
Eo SK, Lee S, Chun S, Rouse BT. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. Journal of Virology. 75: 569-78. PMID 11134269 DOI: 10.1128/Jvi.75.2.569-578.2001 |
0.47 |
|
| 2000 |
Eo SK, Chun S, Lee S, Rouse BT. On the mechanisms of T cell silencing by IL-10 DNA: Direct and indirect inhibition of T cell functions Cellular Immunology. 206: 59-69. PMID 11161438 DOI: 10.1006/Cimm.2000.1731 |
0.428 |
|
| 2000 |
Deshpande SP, Kumaraguru U, Rouse BT. Why do we lack an effective vaccine against herpes simplex virus infections? Microbes and Infection / Institut Pasteur. 2: 973-8. PMID 10962281 DOI: 10.1016/S1286-4579(00)00339-7 |
0.629 |
|
| 2000 |
Deshpande SP, Kumaraguru U, Rouse BT. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cellular Immunology. 202: 79-87. PMID 10896767 DOI: 10.1006/Cimm.2000.1666 |
0.719 |
|
| 2000 |
Kumaraguru U, Rouse RJ, Nair SK, Bruce BD, Rouse BT. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization. Journal of Immunology (Baltimore, Md. : 1950). 165: 750-9. PMID 10878348 DOI: 10.4049/Jimmunol.165.2.750 |
0.379 |
|
| 2000 |
Kumaraguru U, Rouse BT. Application of the intracellular gamma interferon assay to recalculate the potency of CD8+ T-cell responses to herpes simplex virus Journal of Virology. 74: 5709-5711. PMID 10823879 DOI: 10.1128/Jvi.74.12.5709-5711.2000 |
0.499 |
|
| 2000 |
Deshpande SP, Zheng M, Daheshia M, Rouse BT. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. Journal of Virology. 74: 3517-24. PMID 10729125 DOI: 10.1128/Jvi.74.8.3517-3524.2000 |
0.67 |
|
| 2000 |
Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Investigative Ophthalmology & Visual Science. 41: 453-9. PMID 10670475 |
0.7 |
|
| 1999 |
Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. European Journal of Immunology. 29: 3674-82. PMID 10556823 DOI: 10.1002/(Sici)1521-4141(199911)29:11<3674::Aid-Immu3674>3.0.Co;2-7 |
0.722 |
|
| 1999 |
Chun S, Daheshia M, Lee S, Rouse BT. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cellular Immunology. 194: 194-204. PMID 10383822 DOI: 10.1006/Cimm.1999.1500 |
0.396 |
|
| 1999 |
Daheshia M, Deshpande S, Chun S, Kuklin NA, Rouse BT. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice. Virology. 257: 168-76. PMID 10208930 DOI: 10.1006/Viro.1999.9613 |
0.707 |
|
| 1999 |
Kumaraguru U, Davis I, Rouse BT. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus Journal of Neurovirology. 5: 42-47. PMID 10190689 DOI: 10.3109/13550289909029744 |
0.466 |
|
| 1998 |
Banks TA, Hariharan MJ, Rouse BT. Assessing Cell-Mediated Immune Responses to HSV in Murine Systems. Methods in Molecular Medicine. 10: 327-43. PMID 21374239 DOI: 10.1385/0-89603-347-3:327 |
0.504 |
|
| 1998 |
Daheshia M, Feldman LT, Rouse BT. Herpes simplex virus latency and the immune response Current Opinion in Microbiology. 1: 430-435. PMID 10066506 DOI: 10.1016/S1369-5274(98)80061-1 |
0.463 |
|
| 1998 |
Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea Experimental Eye Research. 67: 619-624. PMID 9990326 DOI: 10.1006/Exer.1998.0565 |
0.547 |
|
| 1998 |
Davis IA, Rouse BT. Immune responsiveness of lymphotoxin-α-deficient mice: Two reconstitution models Cellular Immunology. 189: 116-124. PMID 9790725 DOI: 10.1006/Cimm.1998.1371 |
0.37 |
|
| 1998 |
Davis IA, Knight KA, Rouse BT. The spleen and organized lymph nodes are not essential for the development of gut-induced mucosal immune responses in lymphotoxin-α deficient mice Clinical Immunology and Immunopathology. 89: 150-159. PMID 9787117 DOI: 10.1006/Clin.1998.4601 |
0.372 |
|
| 1998 |
Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: Implications in herpetic stromal keratitis Journal of Interferon and Cytokine Research. 18: 681-690. PMID 9781806 DOI: 10.1089/Jir.1998.18.681 |
0.489 |
|
| 1998 |
Manickan E, Daheshia M, Kuklin N, Chun S, Rouse BT. Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10. Immunology. 94: 129-34. PMID 9741332 DOI: 10.1046/J.1365-2567.1998.00496.X |
0.474 |
|
| 1998 |
Yu Z, Karem KL, Kanangat S, Manickan E, Rouse BT. Protection by minigenes: a novel approach of DNA vaccines. Vaccine. 16: 1660-7. PMID 9713944 DOI: 10.1016/S0264-410X(98)00065-6 |
0.464 |
|
| 1998 |
Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine. 16: 1103-10. PMID 9682365 DOI: 10.1016/S0264-410X(98)80105-9 |
0.408 |
|
| 1998 |
Kuklin NA, Daheshia M, Chun S, Rouse BT. Immunomodulation by mucosal gene transfer using TGF-β DNA Journal of Clinical Investigation. 102: 438-444. PMID 9664086 DOI: 10.1172/Jci2803 |
0.406 |
|
| 1998 |
Thomas J, Rouse BT. Immunopathology of herpetic stromal keratitis: Discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients Journal of Immunology. 160: 3965-3970. PMID 9558104 |
0.399 |
|
| 1998 |
Rouse BT, Nair S, Rouse RJ, Yu Z, Kuklin N, Karem K, Manickan E. DNA vaccines and immunity to herpes simplex virus. Current Topics in Microbiology and Immunology. 226: 69-78. PMID 9479836 DOI: 10.1007/978-3-642-80475-5_5 |
0.433 |
|
| 1998 |
Kuklin NA, Daheshia M, Marconi PC, Krisky DM, Rouse RJ, Glorioso JC, Manican E, Rouse BT. Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines. Virology. 240: 245-53. PMID 9454698 DOI: 10.1006/Viro.1997.8926 |
0.335 |
|
| 1998 |
Gangappa S, Manickan E, Rouse BT. Control of herpetic stromal keratitis using CTLA4Ig fusion protein Clinical Immunology and Immunopathology. 86: 88-94. PMID 9434800 DOI: 10.1006/Clin.1997.4460 |
0.528 |
|
| 1998 |
Kumaraguru U, Rouse BT. DNA vaccines for the prophylaxis and modulation of HSV infections Expert Opinion On Investigational Drugs. 7: 219-224. DOI: 10.1517/13543784.7.2.219 |
0.365 |
|
| 1998 |
Chun S, Daheshia M, Kuklin NA, Rouse BT. Modulation of Viral Immunoinflammatory Responses with Cytokine DNA Administered by Different Routes Journal of Virology. 72: 5545-5551. DOI: 10.1128/Jvi.72.7.5545-5551.1998 |
0.354 |
|
| 1997 |
Thomas J, Rouse BT. Immunopathogenesis of herpetic ocular disease Immunologic Research. 16: 375-386. PMID 9439761 DOI: 10.1007/Bf02786400 |
0.503 |
|
| 1997 |
Manickan E, Yu Z, Rouse BT. DNA immunization of neonates induces immunity despite the presence of maternal antibody Journal of Clinical Investigation. 100: 2371-2375. PMID 9410917 DOI: 10.1172/Jci119777 |
0.382 |
|
| 1997 |
Davis IA, Rouse BT. A skeptical look at viral immune evasion Frontiers in Bioscience : a Journal and Virtual Library. 2. PMID 9386215 |
0.306 |
|
| 1997 |
Manickan E, Karem KL, Rouse BT. DNA vaccines - A modern gimmick or a boon to vaccinology? Critical Reviews in Immunology. 17: 139-154. PMID 9094450 DOI: 10.1615/Critrevimmunol.V17.I2.20 |
0.301 |
|
| 1997 |
Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. Journal of Leukocyte Biology. 61: 125-32. PMID 9021916 DOI: 10.1002/Jlb.61.2.125 |
0.399 |
|
| 1997 |
Karem KL, Bowen J, Kuklin N, Rouse BT. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. The Journal of General Virology. 427-34. PMID 9018066 DOI: 10.1099/0022-1317-78-2-427 |
0.416 |
|
| 1997 |
Thomas J, Gangappa S, Kanangat S, Rouse BT. On the Essential Involvement of Neutrophils in the Immunopathologic Disease: Herpetic Stromal Keratitis Journal of Immunology. 158: 1383-1391. PMID 9013983 |
0.47 |
|
| 1997 |
Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. Journal of Virology. 71: 3138-3145. DOI: 10.1128/Jvi.71.4.3138-3145.1997 |
0.355 |
|
| 1996 |
Karem L K, Kanangat S, Rouse BT. Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains Vaccine. 14: 1495-1502. PMID 9014289 DOI: 10.1016/S0264-410X(96)00118-1 |
0.394 |
|
| 1996 |
Rouse BT. Virus-induced immunopathology Advances in Virus Research. 47: 353-376. PMID 8895836 DOI: 10.1016/S0065-3527(08)60739-3 |
0.554 |
|
| 1996 |
Yu Z, Manickan E, Rouse BT. Role of interferon-γ in immunity to herpes simplex virus Journal of Leukocyte Biology. 60: 528-532. PMID 8864138 DOI: 10.1002/Jlb.60.4.528 |
0.558 |
|
| 1996 |
Manickan E, Yu Z, Rouse RJ, Wire WS, Rouse BT. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunology. 8: 53-61. PMID 8825290 DOI: 10.1089/Vim.1995.8.53 |
0.519 |
|
| 1996 |
Babu JS, Nair S, Kanda P, Rouse BT. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. Vaccine. 13: 1669-76. PMID 8719518 DOI: 10.1016/0264-410X(95)00120-P |
0.408 |
|
| 1996 |
Bouley DM, Kanangat S, Rouse BT. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis Clinical Immunology and Immunopathology. 80: 23-30. PMID 8674236 DOI: 10.1006/Clin.1996.0090 |
0.521 |
|
| 1996 |
Kanangat S, Babu JS, Knipe DM, Rouse BT. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: Selective upregulation of IL-6 gene expression Virology. 219: 295-300. PMID 8623544 DOI: 10.1006/Viro.1996.0250 |
0.404 |
|
| 1996 |
Kanangat S, Blair P, Reddy R, Daheshia M, Godfrey V, Rouse BT, Wilkinson E, Deheshia M. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. European Journal of Immunology. 26: 161-5. PMID 8566060 DOI: 10.1002/Eji.1830260125 |
0.424 |
|
| 1996 |
Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus Journal of Virology. 70: 101-107. PMID 8523513 DOI: 10.1128/Jvi.70.1.101-107.1996 |
0.561 |
|
| 1996 |
Daheshia M, Kanangat S, Thomas J, Rouse BT. Expression of inducihle nitric oxide synihcta.se during occular herpes simplex viral infection Faseb Journal. 10. |
0.335 |
|
| 1996 |
Kuklin N, Daheshia M, Karem K, Rouse BT. Intranasal administration of plasmid DNA encoding HSV glycoprotein B induces common mucosal immune response and protection against mucosal HSV challenge Faseb Journal. 10. |
0.301 |
|
| 1996 |
Thomas J, Kanangat S, Knipe PM, Rouse BT. Viral replication is required for the expression of chemokines, proinflammalory cytokines and il-12 in the cornea for manifestation of hsk Faseb Journal. 10. |
0.393 |
|
| 1995 |
Karem KL, Chatfield S, Kuklin N, Rouse BT. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice Infection and Immunity. 63: 4557-4563. PMID 7591105 DOI: 10.1128/Iai.63.12.4557-4563.1995 |
0.38 |
|
| 1995 |
Bouley DM, Kanangat S, Wire W, Rouse BT. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice Journal of Immunology. 155: 3964-3971. PMID 7561104 |
0.371 |
|
| 1995 |
Nair S, Buiting AM, Rouse RJ, Van Rooijen N, Huang L, Rouse BT. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. International Immunology. 7: 679-88. PMID 7547695 DOI: 10.1093/Intimm/7.4.679 |
0.387 |
|
| 1995 |
Kanangat S, Nair S, Babu JS, Rouse BT. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. Journal of Leukocyte Biology. 57: 310-6. PMID 7531747 DOI: 10.1002/Jlb.57.2.310 |
0.414 |
|
| 1995 |
Manickan E, Rouse BT. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models Journal of Virology. 69: 8178-8179. PMID 7494346 |
0.452 |
|
| 1995 |
Manickan E, Francotte M, Kuklin N, Dewerchin M, Molitor C, Gheysen D, Slaoui M, Rouse BT. Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. Journal of Virology. 69: 4711-4716. DOI: 10.1128/Jvi.69.8.4711-4716.1995 |
0.516 |
|
| 1995 |
Niemialtowski M, Rouse BT. Evidence of involvement of CD4+ T cells and CD8+ cytotoxic T lymphocyte precursors (CTL-p) in response to intracorneal P511 minor histoincompatible allogeneic tumors Polish Journal of Immunology. 20: 45-55. |
0.373 |
|
| 1994 |
Banks TA, Jenkins FJ, Kanangat S, Nair S, Dasgupta S, Foster CM, Rouse BT. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology. 200: 236-45. PMID 8128625 DOI: 10.1006/Viro.1994.1181 |
0.466 |
|
| 1994 |
Niemialtowski MG, Godfrey VL, Rouse BT. Quantitative studies on CD4<sup>+</sup> and CD8<sup>+</sup> cytotoxic T lymphocyte responses against herpes simplex virus type 1 in normal and β2-m deficient mice Immunobiology. 190: 183-194. PMID 7916329 DOI: 10.1016/S0171-2985(11)80268-8 |
0.409 |
|
| 1994 |
Niemiałtowski MG, Rouse BT. Cytotoxic T lymphocyte response to herpes simplex virus type 1 is composed of both CD8+ and CD4+ T cell phenotypes in acute and memory states Archivum Immunologiae Et Therapiae Experimentalis. 42: 319-324. PMID 7487374 |
0.328 |
|
| 1994 |
Rouse RJ, Nair SK, Lydy SL, Bowen JC, Rouse BT. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. Journal of Virology. 68: 5685-5689. DOI: 10.1128/Jvi.68.9.5685-5689.1994 |
0.471 |
|
| 1994 |
Niemialtowski MG, Rouse BT. Immunopathology of the herpetic stromal keratitis: Model studies Polish Journal of Immunology. 19: 289-311. |
0.363 |
|
| 1994 |
Niemialtowski M, Kita J, Gierynska M, Rouse BT. The comparative analysis of human (HSV-1) and equine (EHV-1) herpes viruses. I. Structure of virion, its immunogenicity and humoral and cellular immunity during infection Polish Journal of Immunology. 19: 3-24. |
0.358 |
|
| 1993 |
Daniel SL, Legendre AM, Moore RN, Rouse BT. Isolation and functional studies on feline bone marrow derived macrophages. Veterinary Immunology and Immunopathology. 36: 107-22. PMID 8475618 DOI: 10.1016/0165-2427(93)90101-9 |
0.33 |
|
| 1993 |
Mercadal CM, Slaoui M, Brown SM, Rouse BT. Efficacy of the herpes simplex virus types 1 and 2 mutant viruses to confer protection against zosteriform spread in mice. Viral Immunology. 6: 35-42. PMID 8386516 DOI: 10.1089/Vim.1993.6.35 |
0.477 |
|
| 1993 |
Martin S, Mercadal CM, Weir JP, Rouse BT. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoproteiC varies between individual mice and is dependent on the form of immunization Viral Immunology. 6: 21-33. PMID 8386515 DOI: 10.1089/Vim.1993.6.21 |
0.458 |
|
| 1993 |
Reiss CS, Rouse BT. The current status of viral immunology Immunology Today. 14: 333-335. PMID 8103337 DOI: 10.1016/0167-5699(93)90229-E |
0.394 |
|
| 1993 |
Mercadal CM, Bouley DM, Destephano D, Rouse BT. Herpetic stromal keratitis in the reconstituted scid mouse model Journal of Virology. 67: 3404-3408. PMID 8098778 DOI: 10.1128/Jvi.67.6.3404-3408.1993 |
0.523 |
|
| 1993 |
Banks TA, Nair S, Rouse BT. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus Journal of Virology. 67: 613-616. PMID 7677961 DOI: 10.1128/Jvi.67.1.613-616.1993 |
0.374 |
|
| 1993 |
Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. Journal of Virology. 67: 4062-4069. DOI: 10.1128/Jvi.67.7.4062-4069.1993 |
0.442 |
|
| 1992 |
Bowen JC, Daniel S, Rouse BT. Virus infections and cytokines: Can we manage the interactions¿? International Reviews of Immunology. 8: 33-41. PMID 1573318 DOI: 10.3109/08830189209056639 |
0.411 |
|
| 1992 |
Nair S, Zhou F, Reddy R, Huang L, Rouse BT. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. The Journal of Experimental Medicine. 175: 609-12. PMID 1531064 DOI: 10.1084/Jem.175.2.609 |
0.411 |
|
| 1992 |
Schmid DS, Rouse BT. The role of T cell immunity in control of herpes simplex virus Current Topics in Microbiology and Immunology. 179: 57-74. PMID 1499350 DOI: 10.1007/978-3-642-77247-4_4 |
0.482 |
|
| 1992 |
Doymaz MZ, Rouse BT. Immunopathology of herpes simplex virus infections Current Topics in Microbiology and Immunology. 179: 121-136. PMID 1499346 DOI: 10.1007/978-3-642-77247-4_8 |
0.505 |
|
| 1992 |
Nair S, Zhou X, Huang L, Rouse BT. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines Journal of Immunological Methods. 152: 237-243. PMID 1386866 DOI: 10.1016/0022-1759(92)90145-J |
0.336 |
|
| 1992 |
Zhou F, Rouse BT, Huang L. Prolonged Survival of Thymomabearing Mice after Vaccination with a Soluble Protein Antigen Entrapped in Liposomes: A Model Study Cancer Research. 52: 6287-6291. PMID 1384958 |
0.339 |
|
| 1992 |
Doymaz MZ, Rouse BT. Herpetic stromal keratitis: An immunopathologic disease mediated by CD4+ T lymphocytes Investigative Ophthalmology and Visual Science. 33: 2165-2173. PMID 1351475 |
0.411 |
|
| 1992 |
Coker LA, Mercadal CM, Rouse BT, Moore RN. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. Journal of Leukocyte Biology. 51: 305-6. PMID 1347313 DOI: 10.1002/Jlb.51.3.305 |
0.36 |
|
| 1992 |
Niemialtowski MG, Rouse BT. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye Journal of Immunology. 148: 1864-1870. PMID 1347309 |
0.361 |
|
| 1992 |
Banks TA, Rouse BT. Herpesviruses-immune escape artists? Clinical Infectious Diseases. 14: 933-941. PMID 1315587 DOI: 10.1093/Clinids/14.4.933 |
0.431 |
|
| 1991 |
Allen EM, Weir JP, Martin S, Mercadal C, Rouse BT. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity. Viral Immunology. 3: 207-15. PMID 2175194 DOI: 10.1089/Vim.1990.3.207 |
0.419 |
|
| 1991 |
Doymaz MZ, Foster CM, Destephano D, Rouse BT. MHC II-restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clinical Immunology and Immunopathology. 61: 398-409. PMID 1934628 DOI: 10.1016/S0090-1229(05)80011-X |
0.455 |
|
| 1991 |
Mester JC, Glorioso JC, Rouse BT. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. The Journal of Infectious Diseases. 163: 263-9. PMID 1846388 DOI: 10.1093/Infdis/163.2.263 |
0.376 |
|
| 1991 |
Mercadal CM, Martin S, Rouse BT. Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation Viral Immunology. 4: 177-186. PMID 1687350 DOI: 10.1089/Vim.1991.4.177 |
0.481 |
|
| 1991 |
Mester JC, Rouse BT. The mouse model and understanding immunity to herpes simplex virus Reviews of Infectious Diseases. 13: S935-S945. PMID 1664131 DOI: 10.1093/clind/13.Supplement_11.S935 |
0.389 |
|
| 1991 |
Banks TA, Allen EM, Dasgupta S, Sandri-Goldin R, Rouse BT. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27. Journal of Virology. 65: 3185-3191. DOI: 10.1128/Jvi.65.6.3185-3191.1991 |
0.464 |
|
| 1990 |
Kolaitis G, Doymaz M, Rouse BT. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus Immunology. 71: 101-106. PMID 2210799 |
0.362 |
|
| 1990 |
Martin S, Zhu X, Silverstein SJ, Courtney RJ, Yao F, Jenkins FJ, Rouse BT. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0 Journal of General Virology. 71: 2391-2399. PMID 2172452 DOI: 10.1099/0022-1317-71-10-2391 |
0.479 |
|
| 1990 |
Brynestad K, Babbitt B, Huang L, Rouse BT. Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: Implications for subunit vaccines Journal of Virology. 64: 680-685. PMID 2153234 DOI: 10.1128/Jvi.64.2.680-685.1990 |
0.326 |
|
| 1989 |
Horohov DW, Moore RN, Rouse BT. The regulation of herpes simplex virus-specific CTL induction by suppressor cells. Viral Immunology. 1: 55-68. PMID 2855699 DOI: 10.1089/Vim.1987.1.55 |
0.509 |
|
| 1989 |
Weir JP, Bennett M, Allen EM, Elkins KL, Martin S, Rouse BT. Recombinant vaccinia virus expressing the herpes simplex virus Type 1 glycoprotein C protects mice against herpes simplex virus challenge Journal of General Virology. 70: 2587-2594. PMID 2794972 DOI: 10.1099/0022-1317-70-10-2587 |
0.491 |
|
| 1989 |
Rouse BT, Hartley D, Doherty PC. Consequences of exposure to ionizing radiation for effector T cell function in vivo Viral Immunology. 2: 69-78. PMID 2789064 DOI: 10.1089/Vim.1989.2.69 |
0.506 |
|
| 1989 |
Martin S, Cantin E, Rouse BT. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins Journal of General Virology. 70: 1359-1370. PMID 2543783 DOI: 10.1099/0022-1317-70-6-1359 |
0.541 |
|
| 1989 |
Newell CK, Sendele D, Rouse BT. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis Regional Immunology. 2: 366-369. PMID 2518571 |
0.316 |
|
| 1989 |
Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. Journal of Virology. 63: 769-775. DOI: 10.1128/Jvi.63.2.769-775.1989 |
0.494 |
|
| 1988 |
Martin S, Cantin E, Rouse BT. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections Annals of the New York Academy of Sciences. 532: 257-272. PMID 2845846 DOI: 10.1111/J.1749-6632.1988.Tb36344.X |
0.496 |
|
| 1988 |
Ho RJ, Ting-Beall HP, Rouse BT, Huang L. Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus. Biochemistry. 27: 500-6. PMID 2831962 DOI: 10.1021/Bi00401A072 |
0.341 |
|
| 1988 |
Wyckoff JH, Osmand AP, Eisenberg RJ, Cohen GH, Rouse BT. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D Immunobiology. 177: 134-148. PMID 2456985 DOI: 10.1016/S0171-2985(88)80034-2 |
0.416 |
|
| 1988 |
Rouse BT, Norley S, Martin S. Antiviral cytotoxic t lymphocyte induction and vaccination Reviews of Infectious Diseases. 10: 16-33. PMID 2451265 DOI: 10.1093/Clinids/10.1.16 |
0.514 |
|
| 1988 |
Martin S, Courtney RJ, Fowler G, Rouse BT. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. Journal of Virology. 62: 2265-2273. DOI: 10.1128/Jvi.62.7.2265-2273.1988 |
0.521 |
|
| 1987 |
Lathey JL, Courtney RJ, Rouse BT. Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C Viral Immunology. 1: 13-23. PMID 3509672 DOI: 10.1089/Vim.1987.1.13 |
0.304 |
|
| 1987 |
Lathey JL, Martin S, Rouse BT. Suppression of delayed type hypersensitivity to herpes simplex virus type 1 following immunization with anti-idiotypic antibody: An example of split tolerance Journal of General Virology. 68: 1093-1102. PMID 3033128 DOI: 10.1099/0022-1317-68-4-1093 |
0.475 |
|
| 1987 |
Martin S, Rouse BT. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing Herpes simplex virus type 1 glycoprotein D: Clearance of local infection Journal of Immunology. 138: 3431-3437. PMID 3033075 |
0.434 |
|
| 1987 |
Martin S, Moss B, Berman PW, Laskey LA, Rouse BT. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. Journal of Virology. 61: 726-734. DOI: 10.1128/jvi.61.3.726-734.1987 |
0.365 |
|
| 1986 |
Rouse BT, Horohov DW. Immunosuppression in viral infections Reviews of Infectious Diseases. 8: 850-873. PMID 3025993 DOI: 10.1093/Clinids/8.6.850 |
0.515 |
|
| 1986 |
Turtinen LW, Lathey JL, Rouse BT. Estimation of the B lymphocyte precursor frequencies to herpes simplex type 1 glycoproteins by a limiting dilution assay Journal of Medical Virology. 20: 357-362. PMID 3025354 DOI: 10.1002/Jmv.1890200408 |
0.32 |
|
| 1986 |
Ho RJ, Rouse BT, Huang L. Destabilization of target-sensitive immunoliposomes by antigen binding--a rapid assay for virus. Biochemical and Biophysical Research Communications. 138: 931-7. PMID 3017345 DOI: 10.1016/S0006-291X(86)80585-X |
0.448 |
|
| 1986 |
Horohov DW, Wyckoff JH, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor Journal of Virology. 58: 331-338. PMID 3009850 DOI: 10.1128/Jvi.58.2.331-338.1986 |
0.462 |
|
| 1986 |
Horohov DW, Moore RN, Rouse BT. Herpes simplex virus-specific lymphoproliferation: an analysis of the involvement of lymphocyte subsets. Immunobiology. 170: 460-73. PMID 3005161 DOI: 10.1016/S0171-2985(85)80069-3 |
0.495 |
|
| 1986 |
Norley SG, Huang L, Rouse BT. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: An effective means of inhibiting virus replication in vitro Journal of Immunology. 136: 681-685. PMID 3001182 |
0.314 |
|
| 1986 |
Horohov DW, Rouse BT. Virus-induced immunosuppression Veterinary Clinics of North America - Small Animal Practice. 16: 1097-1127. PMID 2947378 DOI: 10.1016/S0195-5616(86)50131-5 |
0.489 |
|
| 1986 |
Horohov DW, Wyckoff JH, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor. Journal of Virology. 58: 331-338. DOI: 10.1128/jvi.58.2.331-338.1986 |
0.34 |
|
| 1985 |
Horohov DW, Moore RN, Rouse BT. Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells Journal of Virology. 56: 1-6. PMID 2993641 DOI: 10.1128/Jvi.56.1.1-6.1985 |
0.465 |
|
| 1985 |
Horohov DW, Moore RN, Rouse BT. Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice Journal of Virology. 54: 798-803. PMID 2987531 DOI: 10.1128/Jvi.54.3.798-803.1985 |
0.478 |
|
| 1985 |
Prymowicz D, Moore RN, Rouse BT. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice Journal of Immunology. 134: 2683-2688. PMID 2579150 |
0.372 |
|
| 1984 |
Moore RN, Larsen HS, Horohov DW, Rouse BT. Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science (New York, N.Y.). 223: 178-81. PMID 6606850 DOI: 10.1126/Science.6606850 |
0.328 |
|
| 1984 |
Rouse BT, Horohov DW. Cytotoxic T lymphocytes in herpesvirus infections Veterinary Immunology and Immunopathology. 6: 35-66. PMID 6330966 DOI: 10.1016/0165-2427(84)90048-5 |
0.315 |
|
| 1984 |
Rouse BT, Wagner H. Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice Immunology. 51: 57-64. PMID 6317545 |
0.396 |
|
| 1984 |
Larsen HS, Feng MF, Horohov DW, Moore RN, Rouse BT. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. Journal of Virology. 50: 56-59. DOI: 10.1128/Jvi.50.1.56-59.1984 |
0.458 |
|
| 1983 |
Rouse BT, Larsen HS, Wagner H. Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis Infection and Immunity. 39: 785-792. PMID 6299949 DOI: 10.1128/Iai.39.2.785-792.1983 |
0.517 |
|
| 1983 |
Schmid DS, Rouse BT. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: Differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors Journal of Immunology. 131: 479-484. PMID 6223080 |
0.41 |
|
| 1983 |
Larsen HS, Russell RG, Rouse BT. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infection and Immunity. 41: 197-204. DOI: 10.1128/Iai.41.1.197-204.1983 |
0.507 |
|
| 1982 |
Wagner H, Hardt C, Rouse BT, Röllinghoff M, Scheurich P, Pfizenmaier K. Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. The Journal of Experimental Medicine. 155: 1876-81. PMID 6978927 DOI: 10.1084/Jem.155.6.1876 |
0.373 |
|
| 1982 |
Schmid DS, Larsen HS, Rouse BT. Role of Ia antigen expression and secretory function of accessory cells in the induction of cytotoxic T lymphocyte responses against herpes simplex virus Infection and Immunity. 37: 1138-1147. PMID 6290391 DOI: 10.1128/Iai.37.3.1138-1147.1982 |
0.437 |
|
| 1982 |
Naylor PT, Larsen HS, Huang L, Rouse BT. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes Infection and Immunity. 36: 1209-1216. PMID 6284643 DOI: 10.1128/Iai.36.3.1209-1216.1982 |
0.451 |
|
| 1981 |
Eberle R, Russell RG, Rouse BT. Cell-mediated immunity to herpes simplex virus: Recognition of type-specific and type-common surface antigens by cytotoxic T cell populations Infection and Immunity. 34: 795-803. PMID 6277790 DOI: 10.1128/Iai.34.3.795-803.1981 |
0.496 |
|
| 1981 |
Kohl S, Lawman MJ, Rouse BT, Cahall DL. Effect of herpes simplex virus infection on murine antibody-dependent cellular cytotoxicity and natural killer cytotoxicity. Infection and Immunity. 31: 704-711. DOI: 10.1128/iai.31.2.704-711.1981 |
0.334 |
|
| 1980 |
Grewal AS, Rouse BT. Destruction of virus infected cells by neutrophils and complement Experientia. 36: 352-354. PMID 6245915 DOI: 10.1007/BF01952322 |
0.364 |
|
| 1980 |
Rouse BT, Lawman MJP. Induction of cytotoxic T lymphocytes against herpes simplex virus type I: Role of accessory cells and amplifying factor Journal of Immunology. 124: 2341-2346. PMID 6245140 |
0.399 |
|
| 1980 |
Rouse BT, Babiuk LA, Henson PM. Neutrophils in antiviral immunity: Inhibition of virus replication by a mediator produced by bovine neutrophils Journal of Infectious Diseases. 141: 223-232. PMID 6154112 DOI: 10.1093/Infdis/141.2.223 |
0.452 |
|
| 1980 |
Lawman MJ, Rouse BT, Courtney RJ, Walker RD. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infection and Immunity. 27: 133-139. DOI: 10.1128/Iai.27.1.133-139.1980 |
0.547 |
|
| 1979 |
Grewal AS, Rouse BT. Characterization of bovine leukocytes involved in antibody-dependent cell cytotoxicity. International Archives of Allergy and Applied Immunology. 60: 169-77. PMID 468390 DOI: 10.1159/000232339 |
0.316 |
|
| 1979 |
Rouse BT, Babiuk LA. Mechanisms of viral immunopathology Advances in Veterinary Science and Comparative Medicine. 23: 103-136. PMID 317775 DOI: 10.1016/B978-0-12-039223-0.50011-1 |
0.497 |
|
| 1979 |
Babiuk LA, Rouse BT. Immune control of herpesvirus latency Canadian Journal of Microbiology. 25: 267-274. PMID 222416 |
0.338 |
|
| 1978 |
Fujimiya Y, Rouse BT, Babiuk L. Human neutrophil mediated destruction of antibody sensitized herpes simplex virus type I infected cells Canadian Journal of Microbiology. 24: 182-186. PMID 565669 DOI: 10.1139/M78-031 |
0.47 |
|
| 1978 |
Rouse BT, Babiuk LA. Mechanisms of recovery from Herpesvirus infections -a review Canadian Journal of Comparative Medicine. 42: 414-427. PMID 217506 |
0.387 |
|
| 1978 |
Fujimiya Y, Babiuk LA, Rouse BT. Direct lymphocytotoxicity against herpes simplex virus infected cells Canadian Journal of Microbiology. 24: 1076-1081. PMID 213180 DOI: 10.1139/M78-177 |
0.467 |
|
| 1978 |
Rouse BT, Babiuk LA, Henson PM. Neutrophils are mediators of antiviral immunity Experientia. 34: 346-348. PMID 204508 DOI: 10.1007/Bf01923026 |
0.396 |
|
| 1978 |
Babiuk LA, Rouse BT. Interactions between effector cell activity and lymphokines: implications for recovery from herpesvirus infections International Archives of Allergy and Applied Immunology. 57: 62-73. PMID 25244 DOI: 10.1159/000232085 |
0.502 |
|
| 1977 |
Rouse BT, Grewal AS, Babiuk LA, Fujimiya Y. Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement Infection and Immunity. 18: 660-665. PMID 201564 DOI: 10.1128/Iai.18.3.660-665.1977 |
0.4 |
|
| 1977 |
Babiuk LA, Rouse BT. Bovine type II interferon: activity in heterologous cells Intervirology. 8: 250-256. PMID 194868 DOI: 10.1159/000148900 |
0.325 |
|
| 1977 |
Grewal AS, Rouse BT, Babiuk LA. Mechanisms of resistance to herpesviruses: comparison of the effectiveness of different cell types in mediating antibody dependent cell mediated cytotoxicity Infection and Immunity. 15: 698-703. PMID 192672 DOI: 10.1128/Iai.15.3.698-703.1977 |
0.432 |
|
| 1977 |
Rouse BT, Babiuk LA. The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells Journal of Immunology. 118: 618-624. PMID 190317 |
0.366 |
|
| 1977 |
Rouse BT, Grewal AS, Babiuk LA, Fujimiya Y. Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement. Infection and Immunity. 18: 660-665. DOI: 10.1128/iai.18.3.660-665.1977 |
0.307 |
|
| 1976 |
Rouse BT, Wardley RC, Babiuk LA. Antibody dependent cell mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erythrocyte and herpesvirus infected bovine target cells Infection and Immunity. 13: 1433-1441. PMID 1270149 DOI: 10.1128/Iai.13.5.1433-1441.1976 |
0.454 |
|
| 1976 |
Babiuk LA, Rouse BT. Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses Infection and Immunity. 13: 1567-1578. PMID 1085748 |
0.36 |
|
| 1976 |
Wardley RC, Babiuk LA, Rouse BT. Polymorph mediated antibody dependent cytotoxicity: modulation of activity by drugs and immune interferon Canadian Journal of Microbiology. 22: 1222-1228. PMID 184903 DOI: 10.1139/M76-181 |
0.449 |
|
| 1976 |
Rouse BT, Wardley RC, Babiuk LA. The role of antibody dependent cytotoxicity in recovery from herpesvirus infections Cellular Immunology. 22: 182-186. PMID 179716 DOI: 10.1016/0008-8749(76)90019-8 |
0.372 |
|
| 1975 |
Rouse BT, Babiuk LA. Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes Cellular Immunology. 17: 43-56. PMID 165005 DOI: 10.1016/S0008-8749(75)80005-0 |
0.359 |
|
| 1975 |
Rouse BT, Babiuk L. Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages Infection and Immunity. 11: 505-511. PMID 163796 DOI: 10.1128/Iai.11.3.505-511.1975 |
0.459 |
|
| 1975 |
Babiuk LA, Wardley RC, Rouse BT. Defense mechanisms against bovine herpesvirus: relationship of virus host cell events to susceptibility to antibody complement cell lysis Infection and Immunity. 12: 958-963. PMID 53206 DOI: 10.1128/Iai.12.5.958-963.1975 |
0.467 |
|
| 1974 |
Rouse BT, Babiuk LA. Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen Infection and Immunity. 10: 681-687. PMID 4426702 DOI: 10.1128/Iai.10.4.681-687.1974 |
0.458 |
|
| 1974 |
Rouse BT, Babiuk LA. Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes Journal of Immunology. 113: 1391-1398. PMID 4370600 |
0.353 |
|
| 1973 |
Rouse BT, Wagner H. The in vivo activity of in vitro immunized mouse thymocytes: III fate of in vitro immunized thymocytes Transplantation. 16: 161-170. PMID 4199580 DOI: 10.1097/00007890-197309000-00001 |
0.357 |
|
| 1969 |
Narayan O, Lang G, Rouse BT. A new influenza A virus infection in turkeys - IV. Experimental susceptibility of domestic birds to virus strain turkey/Ontario 7732/1966 Archiv FüR Die Gesamte Virusforschung. 26: 149-165. PMID 4306362 DOI: 10.1007/BF01241184 |
0.302 |
|
| Show low-probability matches. |